---
figid: PMC7342862__jitc-2020-001119f01
figtitle: Hypothetical diagram showing enhanced protection by intranasally delivered
  BCG (in combination with a sting pathway activator) or with recombinant BCG (VPM1002),
  against SARS-CoV2 viral infection
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7342862
filename: jitc-2020-001119f01.jpg
figlink: pmc/articles/PMC7342862/figure/F1/
number: F1
caption: Hypothetical diagram showing enhanced protection by intranasally delivered
  BCG (in combination with a sting pathway activator) or with recombinant BCG (VPM1002),
  against SARS-CoV2 viral infection. iBALT, induced bronchus associated lymphoid tissue;
  STING, STimulator of INterferon Genes; TLS, tertiary lymphoid structure; DC, Dendritic
  cell; SARS-CoV2, Severe acute respiratory syndrome-coronavirus 2.
papertitle: 'BCG vaccine and COVID-19: implications for infection prophylaxis and
  cancer immunotherapy.'
reftext: Madhuri Koti, et al. J Immunother Cancer. 2020;8(2):e001119.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5422879
figid_alias: PMC7342862__F1
figtype: Figure
redirect_from: /figures/PMC7342862__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7342862__jitc-2020-001119f01.html
  '@type': Dataset
  description: Hypothetical diagram showing enhanced protection by intranasally delivered
    BCG (in combination with a sting pathway activator) or with recombinant BCG (VPM1002),
    against SARS-CoV2 viral infection. iBALT, induced bronchus associated lymphoid
    tissue; STING, STimulator of INterferon Genes; TLS, tertiary lymphoid structure;
    DC, Dendritic cell; SARS-CoV2, Severe acute respiratory syndrome-coronavirus 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STING1
  - FUS
  - BCO1
  - MS4A1
  - KRT20
  - CD4
  - CD8A
  - CD8B
  - CoV-2
  - SARS-CoV-2
---
